Timothy Jackson

Timothy Jackson is a Professor of Retinal Research in the Department of Ophthalmology. He is an internationally recognized clinician-scientist specializing in retinal diseases, macular degeneration, and advanced retinal surgical techniques. His work bridges clinical ophthalmology and translational research, with a strong focus on improving outcomes for patients with complex retinal conditions.

Education & Academic Standing:

• Professor of Retinal Research, Ophthalmology
• HEFCE Clinical Senior Lectureship Award (2011)

Research Interests:
Professor Jackson’s research spans several interrelated domains:

• Macular Degeneration: Investigating wet and dry forms of age-related macular degeneration (AMD), including combination therapies and novel drug delivery systems.
• Retinal Surgery: Advancing vitrectomy techniques for macular hole, submacular hemorrhage, and epiretinal membranes.
• Diabetic Eye Disease: Exploring diabetic retinopathy and its systemic neurologic implications using large-scale biobank data.
• Glaucoma: Leading multicentre trials such as the NAMinG trial evaluating nicotinamide in glaucoma.
• Retinal Imaging & AI: Developing machine learning tools for automated detection of retinal pathologies like venous pulsations and hydroxychloroquine toxicity.

Scientific Awards & Honors:

• American Academy of Ophthalmology Achievement Award (2017)
• American Academy of Ophthalmology Personal Achievement Award (2017)
• Elected to the Retina Society (USA) in 2012
• Acting Treasurer, British and Eire Association of Vitreoretinal Surgeons (2010)

Research Leadership & Funding:
Professor Jackson has led or co-led over 20 research projects, including large-scale clinical trials and feasibility studies. Notable active projects include:

• TIGER Trial: A European multicentre RCT evaluating vitrectomy and subretinal tPA for submacular hemorrhage in AMD.
• GEM Study: Assessing gasless macular hole surgery feasibility.
• NAMinG Trial: Phase III RCT of nicotinamide in glaucoma.
• AI in Retinal Imaging: MRC-funded project for automated detection of spontaneous venous pulsations.
• Diabetic Microangiopathy Platform: Diabetes UK-funded personalised drug screening project.

Clinical & Academic Service:
He contributes extensively to peer review and editorial roles, including for The Lancet, Ophthalmology Retina, and EURETINA. He chairs committees at Moorfields Eye Hospital NHS Foundation Trust and participates in national and international guideline development.